Clinical Trial Update: Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing aerosolized versus intravenous colistin-based regimens in hospitalized COVID-19 patients with bacterial coinfection has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection in COVID-19 Patients

Drugs mentioned

• Colistin (colistin)

Snippet

Sponsor: Beni-Suef University | Conditions: Secondary Bacterial Infection in COVID-19 Patients | Phase 3 | Status: COMPLETED